Richard Auchus
James A Shayman and Andrea S Kevrick Professor of Translational Medicine
Professor of Internal Medicine
Professor of Pharmacology
[email protected]

Available to mentor
Richard Auchus
Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • About

    Steroid biochemistry and related disorders; secondary causes of diabetes and their treatments.

    Qualifications
    • MD
      Washington University in St. Louis School of Medicine, St Louis, 1988
    • PhD
      Washington University in St. Louis School of Medicine, St Louis, 1988
    Center Memberships
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Rogel Cancer Center
    • Center Member
      Center for Cell Plasticity and Organ Design
    • Center Member
      Global REACH
    Research Overview

    Steroid biochemistry and related disorders; secondary causes of diabetes and their treatments.

    Recent Publications See All Publications
    • Journal Article
      Response to Letter to the Editor From Tang and Zhang: "Predictors of Cardiovascular Morbidities in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia".
      Charoensri S, Auchus RJ. J Clin Endocrinol Metab, 2024 Oct 15; 109 (11): e2164 - e2165. DOI:10.1210/clinem/dgae402
      PMID: 38922819
    • Journal Article
      12484 Safety And Pharmacokinetics Of Anti-ACTH Antibody Lu AG13909 In Patients With Classic Congenital Adrenal Hyperplasia: Phase 1 Open-label, Multiple-Ascending-Dose Trial Protocol
      Srirangalingam U, Velusamy A, Binderup ML, Baker B, Flensburg MF, Boserup LP, Luthman J, Benecke H, Auchus RJ. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.285 DOI:10.1210/jendso/bvae163.285
    • Journal Article
      12537 Once Daily Oral Atumelnant (CRN04894) Induces Rapid And Profound Reductions Of Androstenedione And 17-Hydroxyprogesterone In Participants With Classical Congenital Adrenal Hyperplasia: Initial Results From A 12-Week, Phase 2, Open-Label Study
      Auchus RJ, Trainer PJ, Lucas KJ, Bruera D, Marko J, Ayala A, Wu Y, Ferrara-Cook CT, De La Torre E, Krasner A, Lagast H, Luo R, Bachega TASS, Struthers RS, Betz SF, Srirangalingam U. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.249 DOI:10.1210/jendso/bvae163.249
    • Journal Article
      6907 Continued Improvements in Hypertension and Diabetes During Long-Term Osilodrostat Therapy in Patients with Cushing’s Disease: A Pooled Analysis from the Phase III LINC 3 and LINC 4 Studies
      Fleseriu M, Pivonello R, Newell-Price J, Gadelha M, Auchus RJ, Feelders R, Lacroix A, Shimatsu A, Witek P, Bex M, Piacentini A, Pedroncelli AM, Biller BM. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.1175 DOI:10.1210/jendso/bvae163.1175
    • Journal Article
      7152 CAHtalyst: Results From The Randomized, Double-Blind, Placebo-Controlled Period Of A Phase 3 Trial Of Crinecerfont, A Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, In Adults With Classic Congenital Adrenal Hyperplasia
      Auchus RJ, Hamidi O, Pivonello R, Bancos I, Russo G, Witchel SF, Isidori AM, Rodien P, Srirangalingam U, Kiefer FW, Falhammar H, Merke DP, Reisch N, Sturgeon J, Roberts E, Lin VH, Chan JL, Farber R. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.128 DOI:10.1210/jendso/bvae163.128
    • Journal Article
      7212 Racial/Ethnical Differences In Classic And 11-Oxygenated Androgens
      Lee C, Auchus RJ, McDonald J, Rege J, Rainey WE, Turcu AF. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.277 DOI:10.1210/jendso/bvae163.277
    • Journal Article
      9265 Racial/Ethnical Differences in Classic and 11-Oxygenated Androgens
      Lee C, Auchus RJ, McDonald J, Rege J, Rainey WE, Turcu AF. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.276 DOI:10.1210/jendso/bvae163.276
    • Journal Article
      9323 Open-label Results From Grace, A Phase 3 Double-blind, Randomized-withdrawal Study Of The Selective Glucocorticoid Receptor Modulator Relacorilant For The Treatment Of Endogenous Hypercortisolism (Cushing Syndrome)
      Pivonello R, Arnaldi G, Auchus RJ, Badiu CP, Cannavo S, Dischinger U, Dobri GA, Elenkova A, Fazeli PK, Feelders RA, Garcia-Centeno R, Gilis-Januszewska A, Hamidi O, Hannoush ZC, Miller HJ, Ranetti A-E, Recasens M, Reincke M, Rovner S, Salvatori R, Silverstein JM, Stigliano A, Terzolo M, Wang C, Yuen KCJ, Hand AL, Tudor IC, Araque KA, Moraitis AG. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.1287 DOI:10.1210/jendso/bvae163.1287
    Featured News & Stories
    Department News
    Dr. Rich Auchus quoted in CNN article
    Dr. Rich Auchus at the University of Michigan Medical School was quoted in CNN article.